These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


125 related items for PubMed ID: 6635335

  • 1. Alterations in neutral amino acid transport across the blood-brain barrier in hepatic failure.
    Watanabe A, Higashi T, Shiota T, Takei N, Sakata T, Fujiwara M, Nakatsukasa H, Kobayashi M, Nagashima H.
    Res Exp Med (Berl); 1983; 183(1):11-8. PubMed ID: 6635335
    [Abstract] [Full Text] [Related]

  • 2. Serum amino acids in hepatic encephalopathy--effects of branched chain amino acid infusion on serum aminogram.
    Watanabe A, Takesue A, Higashi T, Nagashima N.
    Acta Hepatogastroenterol (Stuttg); 1979 Oct; 26(5):346-57. PubMed ID: 525213
    [Abstract] [Full Text] [Related]

  • 3. Characteristics change in serum amino acid levels in different types of hepatic encephalopathy.
    Watanabe A, Hayashi S, Higashi T, Obata T, Sakata T, Takei N, Shiota T, Nagashima H.
    Gastroenterol Jpn; 1982 Oct; 17(3):218-23. PubMed ID: 7117780
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Infusion of branched-chain enriched amino acid solution in patients with hepatic encephalopathy.
    Freund H, Dienstag J, Lehrich J, Yoshimura N, Bradford RR, Rosen H, Atamian S, Slemmer E, Holroyde J, Fischer JE.
    Ann Surg; 1982 Aug; 196(2):209-20. PubMed ID: 6284073
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Ammonia and amino acid profiles in liver cirrhosis: effects of variables leading to hepatic encephalopathy.
    Holecek M.
    Nutrition; 2015 Jan; 31(1):14-20. PubMed ID: 25220875
    [Abstract] [Full Text] [Related]

  • 14. The BCAA/AAA ratio of plasma amino acids in three different groups of cirrhotics.
    Campollo O, Sprengers D, McIntyre N.
    Rev Invest Clin; 1992 Jan; 44(4):513-8. PubMed ID: 1485030
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Impaired metabolism of methionine in severe liver diseases. I. Clinical and pathophysiological significance of elevated serum methionine levels.
    Higashi T.
    Gastroenterol Jpn; 1982 Apr; 17(2):117-24. PubMed ID: 6286400
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of branched chain amino acid infusion on glucose metabolism in cirrhotic patients with encephalopathy.
    Morioka S, Kanai K, Kako M, Nakajima T, Yoshimi T, Masaka M, Sudo K, Kanno T.
    Gastroenterol Jpn; 1983 Dec; 18(6):553-9. PubMed ID: 6368305
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.